Find therapies in clinical trials near you – page 7

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia

QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Long-Term Study of Imeroprubart in Adults With Graves' Disease

Long-Term Study of Imeroprubart in Adults With Graves' Disease

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy